SCHEMBL25680245

SCHEMBL25680245

C/C(F)=C(\C)c1cccc(Cl)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.49
KDM4E B2RXH2 1/20 0.49
PARP1 P09874 1/20 0.48
SMN1; SMN2 Q16637 3/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
CTSL P07711 1/20 0.44
ALDH1A1 P00352 3/20 0.42
POLB P06746 1/20 0.42
GAA P10253 1/20 0.42
MAPT P10636 1/20 0.42
HPGD P15428 1/20 0.42
TSHR P16473 1/20 0.41
ERCC5 P28715 1/20 0.41
FEN1 P39748 1/20 0.41
SLC6A2 P23975 2/20 0.40
PKM P14618 1/20 0.40
CHRNA1 P02708 1/20 0.40
CHRNG P07510 1/20 0.40
ITGA5 P08648 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18554394 1.00 HTT (0.49) HTTKDM4EPARP1SMN1; SMN2MEN1
SCHEMBL28062724 0.83 PARP1 (0.52) HTTKDM4EPARP1SMN1; SMN2MEN1
SCHEMBL18549722 0.81 HTT (0.47) HTTKDM4EPARP1SMN1; SMN2MEN1
SCHEMBL18591427 0.81 HTT (0.47) HTTKDM4EPARP1SMN1; SMN2MEN1
SCHEMBL18549723 0.81 HTT (0.47) HTTKDM4EPARP1SMN1; SMN2MEN1
SCHEMBL18591426 0.81 HTT (0.44) HTTKDM4EPARP1SMN1; SMN2MEN1
SCHEMBL18549717 0.81 HTT (0.44) HTTKDM4EPARP1SMN1; SMN2MEN1
SCHEMBL18549715 0.81 HTT (0.44) HTTKDM4EPARP1SMN1; SMN2MEN1
Hydrochloric Acid SCHEMBL18578719 0.80 KDM4E (0.46) HTTKDM4EPARP1SMN1; SMN2MEN1
SCHEMBL18549544 0.80 PARP1 (0.50) HTTKDM4EPARP1SMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023114198-A2 METHODS FOR THE SYNTHESIS OF COMPLEMENT FACTOR D INHIBITORS ALEXION PHARMACEUTICALS, INC. (US) 2023-06-22 WO disclosed
WO-2023114200-A2 METHODS FOR THE SYNTHESIS OF COMPLEMENT FACTOR D INHIBITORS AND INTERMEDIATES THEREOF ALEXION PHARMACEUTICALS, INC. (US) 2023-06-22 WO disclosed